TERMIS 2021 | Overcoming barriers to translating cell therapies

Ruud Das, PhD, Scinus Cell Expansion, Bilthoven, The Netherlands, provides an overview of ongoing work surrounding bioreactor technology, which will provide a platform for scaling up the production of cell therapies. Dr Das additionally provides advice for researchers and organizations on translating products to the clinic. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).